Potomac, MD, United States of America

Khalid M Khan

This inventor holds 2 USPTO granted patents. Top assignee: Medstar Health. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Khalid M Khan. Retrieved from https://idiyas.com/inventor/khalid-m-khan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Khalid M Khan: Innovator in COVID-19 Treatment

Introduction

Khalid M Khan is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of COVID-19. His innovative approach targets key inflammatory pathways associated with the disease.

Latest Patents

Khalid M Khan holds 1 patent for his invention titled "Methods for treating COVID-19." This invention focuses on methods that target the inflammasome/caspase1/pyroptosis axis, which is a critical inflammatory pathway in patients infected with SARS-CoV-2. The patent outlines the use of compounds that can effectively inhibit these pathways, offering a potential treatment for COVID-19.

Career Highlights

Khalid M Khan is affiliated with Medstar Health, where he applies his expertise in medical research and innovation. His work is pivotal in advancing treatment options for infectious diseases, particularly in the context of the ongoing pandemic.

Collaborations

Khalid collaborates with esteemed colleagues such as Thomas M Fishbein and Alexander H Kroemer. Their combined efforts contribute to the development of effective medical solutions and enhance the research environment at Medstar Health.

Conclusion

Khalid M Khan's innovative work in treating COVID-19 exemplifies the critical role of inventors in addressing global health challenges. His contributions are vital in the ongoing fight against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…